Patents by Inventor Gustave Bergnes

Gustave Bergnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds, methods and compositions
    Patent number: 7482343
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Grant
    Filed: November 15, 2006
    Date of Patent: January 27, 2009
    Assignees: Cytokinetics, Inc., SmithKline Beecham Corporation
    Inventors: Han-Jie Zhou, David J. Morgans, Jr., Gustave Bergnes, Steven David Knight, Kenneth A. Newlander, Dashyant Dhanak, Nicholas D. Adams
  • Compounds, compositions, and methods
    Patent number: 7476743
    Abstract: 1,2,4-Tiazole-5-ones useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: January 13, 2009
    Assignees: Cytokinetics, Inc., SmithKline Beecham Corporation
    Inventors: Xiangping Qian, Gustave Bergnes, David J. Morgans, Jr., Steven David Knight, Dashyant Dhanak
  • Compounds, compositions and methods
    Publication number: 20090005580
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: June 19, 2008
    Publication date: January 1, 2009
    Inventors: Andrew McDonald, Gustave Bergnes, Bainian Feng, David J. Morgans, JR., Steven David Knight, Kenneth A. Newlander, Dashyant Dhanak, Christopher A. Brook
  • Compounds, compositions, and methods
    Patent number: 7439254
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Grant
    Filed: December 7, 2004
    Date of Patent: October 21, 2008
    Assignee: Cytokinetics, Inc.
    Inventor: Gustave Bergnes
  • Certain chemical entities, compositions, and methods
    Publication number: 20080255182
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: January 7, 2008
    Publication date: October 16, 2008
    Inventors: Xiangping Qian, Andrew I. McDonald, Han-Jie Zhou, Luke W. Ashcraft, Bing Yao, Hong Jiang, Jennifer Kuo Chen Huang, Jianchao Wang, David J. Morgans, Bradley P. Morgan, Gustave Bergnes, Dashyant Dhanak, Steven D. Knight, Nicholas D. Adams, Cynthia A. Parrish, Kevin Duffy, Duke Fitch, Rosanna Tedesco
  • Certain Chemical Entities, Compositions, and Methods
    Publication number: 20080242695
    Abstract: Provided are certain chemical entities, and methods of use to modulate skeletal myosin, skeletal actin, skeletal tropomyosin, skeletal troponin C, skeletal troponin I, skeletal troponin T, and skeletal muscle, including fragments and isoforms thereof, as well as the skeletal sarcomere, and methods of use in the treatment of muscle weakness and/or cachexia, as part of a rehabilitation or conditioning exercise regimen, or in the treatment of fraility, post-polio syndrome, obesity, sarcopenia, wasting syndrome, muscle spasm, and other indications.
    Type: Application
    Filed: March 28, 2008
    Publication date: October 2, 2008
    Inventors: Bradley P. Morgan, David J. Morgans, Gustave Bergnes, Alex Muci, Scott Collibee, Pu-Ping Lu, Luke W. Ashcraft, William F. Browne, Marc Andrew Garard
  • Methods and compositions utilizing quinazolinones
    Publication number: 20080182864
    Abstract: Quinazolinones of formulae (a, b, c and d) are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Application
    Filed: June 28, 2007
    Publication date: July 31, 2008
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Bainian Feng, Whitney W. Smith, John C. Chabala
  • Compounds, Compositions, and Methods
    Publication number: 20080021079
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by inhibiting the activity of KSP are disclosed.
    Type: Application
    Filed: May 5, 2004
    Publication date: January 24, 2008
    Inventors: Han-Jie Zhou, Gustave Bergnes
  • Compounds, compositions, and methods
    Publication number: 20080021050
    Abstract: Compounds, compositions and methods useful for treating cellular proliferative diseases and disorders, for example, by modulating the activity of KSP, are disclosed.
    Type: Application
    Filed: March 12, 2007
    Publication date: January 24, 2008
    Inventors: Gustave Bergnes, Whitney Smith, Bing Yao, David Morgans, Andrew McDonald
  • Methods and compositions utilizing quinazolinones
    Patent number: 7294634
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed.
    Type: Grant
    Filed: July 20, 2004
    Date of Patent: November 13, 2007
    Assignee: Cytokinetics, Inc.
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • Compounds, compositions and methods
    Publication number: 20070254870
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: April 19, 2007
    Publication date: November 1, 2007
    Inventors: Gustave Bergnes, Dashyant Dhanak, Steven Knight, Pu Lu, David Morgans, Kenneth Newlander
  • Compounds, Compositions, and Methods
    Publication number: 20070232597
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by inhibiting the activity of KSP are disclosed.
    Type: Application
    Filed: April 9, 2004
    Publication date: October 4, 2007
    Inventors: Xiangping Qian, Gustave Bergnes, David Morgans Jr.
  • Certain chemical entities, compositions, and methods
    Publication number: 20070219192
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: November 2, 2006
    Publication date: September 20, 2007
    Inventors: Xiangping Qian, Gustave Bergnes, Kenneth Newlander, Duke Fitch, Dashyant Dhanak
  • Compounds, compositions, and methods
    Patent number: 7271167
    Abstract: 1,2,4-Triazin-5-ones useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Grant
    Filed: October 9, 2003
    Date of Patent: September 18, 2007
    Assignee: Cytokinetics, Inc.
    Inventors: Xiangping Qian, Gustave Bergnes, David J. Morgans, Jr.
  • Certain chemical entities, compositions, and methods
    Publication number: 20070197640
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: November 1, 2006
    Publication date: August 23, 2007
    Inventors: Xiangping Qian, Gustave Bergnes
  • Certain chemical entities, compositions, and methods
    Publication number: 20070197481
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: May 6, 2005
    Publication date: August 23, 2007
    Inventors: Xiangping Qian, Andrew McDonald, Han-Jie Zhou, Luke Ashcraft, Bing Yao, Hong Jiang, Jennifer Kuo Chen Huang, Jianchao Wang, David Morgans, Bradley Morgan, Gustave Bergnes, Dashyant Dhanak, Steven Knight, Nicholas Adams, Cynthia Parrish, Kevin Duffy, Duke Fitch, Rosanna Tedesco
  • Certain chemical entities, compositions, and methods
    Publication number: 20070161683
    Abstract: Compounds useful for treating cellular proliferative diseases are disclosed.
    Type: Application
    Filed: November 14, 2006
    Publication date: July 12, 2007
    Inventors: Scott Collibee, Gustave Bergnes, Matthew Hamilton, Bradley Morgan, David Morgans
  • Certain chemical entities, compositions, and methods
    Publication number: 20070161674
    Abstract: Compounds useful for treating cellular proliferative diseases are disclosed.
    Type: Application
    Filed: November 15, 2006
    Publication date: July 12, 2007
    Inventors: Scott Collibee, Zhe Yang, Luke Ashcraft, Gustave Bergnes, Bradley Morgan, David Morgans, Jianchao Wang
  • Certain chemical entities, compositions, and methods
    Publication number: 20070149516
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: November 8, 2006
    Publication date: June 28, 2007
    Inventors: Xiangping Qian, Luke Ashcraft, Jianchao Wang, Bing Yao, Hong Jiang, Gustave Bergnes, Bradley Morgan, David Morgans, Dashyant Dhanak, Steven Knight, Nicholas Adams, Cynthia Parrish, Kevin Duffy, Duke Fitch, Rosanna Tedesco
  • Compounds, methods and compositions
    Publication number: 20070135432
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: November 15, 2006
    Publication date: June 14, 2007
    Inventors: Han-Jie Zhou, David Morgans, Gustave Bergnes, Steven Knight, Kenneth Newlander, Dashyant Dhanak, Nicholas Adams